Sign in
4

Changes in Ownership

Protara Therapeutics, Inc. Filed Acc 0001209191-20-003241

Director acquired 31,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SARGEN GREGORY Director 2020-01-10 Grant or award +31,000 31,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…